BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37029242)

  • 1. LncRNA CASC19: a novel oncogene involved in human cancer.
    Wang S; Qiao C; Fang R; Yang S; Zhao G; Liu S; Li P
    Clin Transl Oncol; 2023 Oct; 25(10):2841-2851. PubMed ID: 37029242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA
    Wang WJ; Guo CA; Li R; Xu ZP; Yu JP; Ye Y; Zhao J; Wang J; Wang WA; Zhang A; Li HT; Wang C; Liu HB
    Aging (Albany NY); 2019 Aug; 11(15):5829-5847. PubMed ID: 31422382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC19 facilitates non-small cell lung cancer cell proliferation and metastasis by targeting the miR-301b-3p/LDLR axis.
    Wang L; Lin C; Sun N; Wang Q; Ding X; Sun Y
    J Gene Med; 2020 Dec; 22(12):e3254. PubMed ID: 32677267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CASC19 promotes gastric cancer progression through preventing CREB1 protein ubiquitin/proteasome-dependent degradation.
    Wang S; Qiao C; Li J; Liu S; Li P
    Carcinogenesis; 2023 May; 44(3):209-220. PubMed ID: 36651836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
    Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma.
    Hou Y; Tang Y; Ma C; Yu J; Jia Y
    Dig Liver Dis; 2023 Jun; 55(6):799-806. PubMed ID: 36805849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non‑coding RNA CASC19 promotes glioma progression by modulating the miR‑454‑3p/RAB5A axis and is associated with unfavorable MRI features.
    Wu YJ; Yang QS; Chen H; Wang JT; Wang WB; Zhou L
    Oncol Rep; 2021 Feb; 45(2):728-737. PubMed ID: 33416169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CASC19: An Oncogenic Long Non-coding RNA in Different Cancers.
    Wu Y; Mou J; Zhou G; Yuan C
    Curr Pharm Des; 2024 Mar; ():. PubMed ID: 38544395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis.
    Liu H; Chen Q; Zheng W; Zhou Y; Bai Y; Pan Y; Zhang J; Shao C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.
    Lu T; Wei GH; Wang J; Shen J
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10462-10471. PubMed ID: 33155202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
    Fan H; Li J; Wang J; Hu Z
    Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-ATB: An indispensable cancer-related long noncoding RNA.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA Brain Cytoplasmic RNA 1 Acts as an Oncogene and Regulates Cell Proliferation and Metastasis in Non-Small Cell Lung Cancer.
    Wang Y; Bai W; Wang M; Yu T; Zhang W
    J Nanosci Nanotechnol; 2019 Apr; 19(4):1978-1985. PubMed ID: 30486938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00958: A promising long non-coding RNA related to cancer.
    Li H; Gao J; Liu L; Zhang S
    Biomed Pharmacother; 2022 Jul; 151():113087. PubMed ID: 35569349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.
    Zhang F; Li J; Xiao H; Zou Y; Liu Y; Huang W
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29057544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
    Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
    Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p.
    Wang S; Jiang M
    Biomed Pharmacother; 2018 Jul; 103():94-100. PubMed ID: 29635134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.